Visit ClinicalTrials.gov
To learn more about the TECTONIC CAD IVL IDE Study.
Abbott is testing a new treatment for people with coronary artery disease. This disease causes the arteries in your heart to narrow due to hard calcium buildup. Before placing a stent (a small tube to keep the artery open), Abbott wants to see if their new treatment can help.
The new treatment investigates Abbott's new SonicForce™ Coronary Intravascular Lithotripsy (IVL) System, a special device to prepare the blood vessels in your heart. The device works by using a balloon to widen the sections of the arteries that are narrowed by calcium. The purpose of this study is to check if the investigational SonicForce™ Coronary IVL System is safe and effective. The system is designed to treat arteries that are severely blocked by calcium before placing a stent.
The device being tested is called the SonicForce™ Coronary IVL System. This system uses a special technique called intravascular lithotripsy to break up hard calcium in your arteries and prepare them for placing a stent.
The investigational SonicForce™ Coronary IVL System uses sound waves to break up the hard calcium buildup in your blood vessels. This makes it easier for your doctor to treat the blood vessel and place a stent more effectively.
When the investigational SonicForce™ Coronary IVL System is powered up, it creates sound waves called lithotripsy. These sound waves travel to the treatment area in your coronary artery and break up the hard calcium buildup in your blood vessel. This helps prepare the artery for placing a stent.
CAUTION: Investigational device. Limited by Federal (U.S.) law to investigational use only. Outside the U.S., the device is subject to local regulatory requirements and is not commercially available.
CL1028213 Rev. C